Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cosmos Health Inc (COSM)

Cosmos Health Inc (COSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leading Pharmacy and Retail Chains

CHICAGO, IL / ACCESSWIRE / July 1, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner...

COSM : 1.0700 (+18.89%)
MarketBeat: Week in Review 11/28 – 12/02

Investors continue to monitor the Federal Reserve, but the MarketBeat team helps you look past the headlines. Here are the stories moving the market this week

JD : 26.76 (-0.41%)
BBY : 82.45 (+0.15%)
ZM : 58.26 (-0.63%)
OGI : 1.5850 (-0.31%)
COSM : 1.0700 (+18.89%)
AAPL : 226.34 (+2.16%)
SOFI : 6.47 (-0.77%)
NIO : 4.62 (-5.13%)
XPEV : 7.92 (-4.81%)
QSR : 69.61 (-0.46%)
DPZ : 493.73 (-0.72%)
Cosmos Holdings May be a Long-Term Buy with Short-Term Risk

Cosmos Holdings stock is up 618% in November likely due to a short squeeze. This article explains why Cosmos Holdings may still be a good long-term investment

COSM : 1.0700 (+18.89%)
GME : 24.18 (-0.78%)
AMC : 5.05 (+0.40%)
PFE : 28.05 (+1.26%)
GSK : 38.84 (+0.99%)
AZN : 77.34 (+0.70%)
Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

/PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the prevention, detection,...

COSM : 1.0700 (+18.89%)
VRAX : 1.2200 (+10.91%)
Cosmos Holdings Appoints Dr. Manfred Ziegler to its Advisory Board

CHICAGO, IL / ACCESSWIRE / July 22 , 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded...

APHA : 15.38 (-0.45%)
COSM : 1.0700 (+18.89%)
Cosmos Holdings Announces Agreement to Acquire Cana Laboratories, a Legacy European Pharmaceutical Company Established in 1928; Vertically Integrating its Manufacturing and R&D Capabilities and Expanding its Product Pipeline with New Brands

CHICAGO, IL / ACCESSWIRE / July 20, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded...

COSM : 1.0700 (+18.89%)
Cosmos Holdings Subsidiary Granted Full Membership in PAGB, A UK-based Consumer Healthcare Association

Products will be listed on PAGB's OTC Directory online, a go-to resource for healthcare professionals

COSM : 1.0700 (+18.89%)
Cosmos Holdings Appoints Dr. Panagiotis Zoumpoulakis to its Advisory Board

CHICAGO, IL / ACCESSWIRE / July 8, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded...

COSM : 1.0700 (+18.89%)
Cosmos Holdings to Acquire LIFE NLB Portfolio of Bone Health Products that Target the Gastrointestinal Microbiome

Acquisition will include all launched and under development bone health products

COSM : 1.0700 (+18.89%)
Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders

CHICAGO, IL / ACCESSWIRE / June 30, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded...

COSM : 1.0700 (+18.89%)

Barchart Exclusives

TDOC Stock Forecast 2025: Can Teladoc Recover from Its Record Lows?
Teladoc Health stock fell to record lows on Wednesday. Can the telehealth stock recover from its slump? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar